Postviral wheezing in childhood: disregulation of airway tone?

儿童期病毒后喘息:气道张力失调?

基本信息

  • 批准号:
    nhmrc : 139024
  • 负责人:
  • 金额:
    $ 38.48万
  • 依托单位:
  • 依托单位国家:
    澳大利亚
  • 项目类别:
    NHMRC Project Grants
  • 财政年份:
    2001
  • 资助国家:
    澳大利亚
  • 起止时间:
    2001-01-01 至 2005-12-31
  • 项目状态:
    已结题

项目摘要

Asthma is a very common childhood condition that is becoming increasingly more common. Wheezing is common in infants and young children following viral infections and is often thought of as the first manifestation of asthma. However, many children and infants who wheeze with viral infections appear to grow out of asthma in their teenage years. Asthma that persists into adult life is usually associated with allergies to common environmental allergens, such as house dust mite and grass pollens. However, many infants who wheeze with viral infections, especially in the first year of life, do not develop allergies in later life, raising the possibility that they did not have the same type of asthma as those whose symptoms persist. This project will study the effects of viral infections on lung function to determine whether particular types of virus can have detrimental effects of lung function lasting for years. We will also examine whether the age at which the infection occurs and the severity of the infection influence the long-term outcome. The project involves studying infants during the recovery phase of respiratory viral infections, older children years after documented infections and experimental animal models that have been infected under controlled conditions. By determining whether respiratory viral infections can have long-term effects on lung function that can mimic asthma, we will advance our understanding of how asthma develops. In addition, specific treatment and preventative strategies could then be developed to prevent these long-term abnormalities, instead of relying on asthma medication (especially inhaled corticosteroids) as is the current practice. Preventative strategies could include encouraging the development of specific vaccines.
哮喘是一种非常常见的儿童疾病,并且越来越常见。喘鸣在病毒感染后的婴幼儿中很常见,通常被认为是哮喘的第一个表现。然而,许多因病毒感染而喘息的儿童和婴儿似乎在青少年时期就摆脱了哮喘。持续到成年的哮喘通常与对常见环境过敏原的过敏有关,如屋尘螨和草花粉。然而,许多因病毒感染而喘息的婴儿,特别是在生命的第一年,在以后的生活中不会发生过敏,这增加了他们与那些症状持续存在的人没有相同类型哮喘的可能性。该项目将研究病毒感染对肺功能的影响,以确定特定类型的病毒是否会对肺功能产生持续多年的有害影响。我们还将研究感染发生的年龄和感染的严重程度是否影响长期结果。该项目涉及研究呼吸道病毒感染恢复期的婴儿、记录感染数年后的大龄儿童以及在受控条件下感染的实验动物模型。通过确定呼吸道病毒感染是否会对肺功能产生类似哮喘的长期影响,我们将进一步了解哮喘是如何发展的。此外,可以制定具体的治疗和预防策略来预防这些长期异常,而不是像目前的做法那样依赖哮喘药物(特别是吸入性皮质类固醇)。预防性战略可包括鼓励开发特定疫苗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

E/Pr Zoltan Hantos其他文献

E/Pr Zoltan Hantos的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
  • 批准号:
    10586398
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
Optimization of a Self-Adjuvanting Particle System for Delivering Respiratory Syncytial Virus Prefusion Protein
用于输送呼吸道合胞病毒预融合蛋白的自我辅助颗粒系统的优化
  • 批准号:
    10666079
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
Mechanistic Study of Inspiratory Training in Childhood Asthma
儿童哮喘吸气训练机制研究
  • 批准号:
    10637048
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
ECHO Renewal for the CANOE Study Cohort
CANOE 研究队列的 ECHO 更新
  • 批准号:
    10745082
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
Impact of SARS-CoV-2 infection on respiratory viral immune responses in children with and without asthma
SARS-CoV-2 感染对患有和不患有哮喘的儿童呼吸道病毒免疫反应的影响
  • 批准号:
    10568344
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
Early Life Pulmonary Infection, Microbiome and Trained Innate Immunity
生命早期肺部感染、微生物组和经过训练的先天免疫
  • 批准号:
    10677304
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
Childhood Allergy and the NeOnatal Environment in St Louis (CANOE-STL) and the Impact of Wheezing Illnesses on Neurocognitive Development of Preschool Children
圣路易斯儿童过敏和新生儿环境 (CANOE-STL) 以及喘息疾病对学龄前儿童神经认知发展的影响
  • 批准号:
    10745142
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
Childhood Allergy and the NeOnatal Environment (CANOE) ECHO Pediatric Follow-Up and New Enrollment
儿童过敏和新生儿环境 (CANOE) ECHO 儿科随访和新入组
  • 批准号:
    10744839
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
Treating Respiratory Emergencies in Children (T-RECS) Feasibility Study
治疗儿童呼吸急症 (T-RECS) 可行性研究
  • 批准号:
    10370791
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
Development and implementation of a pediatric AI multi-modal digital stethoscope and respiratory surveillance system in South Africa
在南非开发和实施儿科人工智能多模态数字听诊器和呼吸监测系统
  • 批准号:
    10740943
  • 财政年份:
    2023
  • 资助金额:
    $ 38.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了